Major study aims to better measure muscle decline in rare diseases
NCT ID NCT05989620
First seen Nov 18, 2025 · Last updated May 14, 2026 · Updated 22 times
Summary
This 24-month observational study will follow up to 1000 people with certain types of muscular dystrophy (LGMD, DM2, or late-onset Pompe disease) to see how well specific muscle function tests work over time. Participants will be between 6 and 50 years old and must have a genetic diagnosis. The goal is to improve how we measure disease progression in future clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LGMD2I are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23298, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.